Tammy Lovell

COVID-19, Oravax Medical, Oramed Pharmaceuticals, BriLife, MigVax
By  Tammy Lovell 09:09 am August 17, 2021
Several Israeli companies and academies are working to develop domestic COVID-19 vaccines to protect against variants of the virus. Phase II clinical trials of the novel BriLife coronavirus vaccine, developed by the Defence Ministry’s Israel Institute for Biological Research (IIBR), are currently taking place in Israel and Georgia. Isreal21c reported that US-based NRx Pharmaceuticals will receive...
Diabetes care
By  Tammy Lovell 07:14 am August 2, 2021
This year marks the centenary of one of the biggest medical breakthroughs in history - the discovery of insulin. It began a century of innovation in which the lives of millions of people with type 1 diabetes have been saved. With recent figures showing nearly half a billion people worldwide have diabetes, innovators are designing new ways of providing care. One radical paradigm shift is the...
Miiskin, skin cancer
By  Tammy Lovell 05:43 am July 21, 2021
Digital health app Miiskin has announced the launch of a new a mole sizing feature.  The skin checking app, which is headquartered in Denmark, allows patients to check if their moles have changed size via augmented reality technology. Its mole sizing feature requires users to photograph their mole next to a reference object such as a coin to measure and record the lesion’s size. This helps users...
Pando health, data security, NHS, DTAC
By  Tammy Lovell 02:07 pm July 12, 2021
UK-based app Pando has come under scrutiny for a security breach which saw NHS patients’ photos automatically uploaded onto users’ smartphones. The clinical communication tool, which has been approved under the NHS Clinical Communication Procurement Framework, is used to send messages, test results, X-Rays and photographs between care teams. It is reportedly used by more than 60,000 NHS staff...
NuvoAir, Series A funding, chronic disease management , spirometer
By  Tammy Lovell 03:06 am June 23, 2021
Stockholm-based digital health company NuvoAir has raised $12 million (€10M) to expand its chronic disease management and clinical trial platforms. The Series A funding round was led by AlbionVC and comes off the back of a record 500% growth for NuvoAir in the first quarter of 2021. KAYA (formerly Enern), Amino Collective and existing shareholders Spiltan, Industrifonden and Novartis Pharma AG (...
Lenus, EQT Ventures, Series A Funding, Online fitness coaching tool
By  Tammy Lovell 08:30 am June 9, 2021
Online fitness coaching platform Lenus today announced it has secured €50 million ($60.9 million) in Series A investment. The round led by EQT Ventures is the largest Series A funding secured in Denmark to date.  WHAT IT DOES Founded in October 2016, Lenus enables health and fitness coaches build online businesses and achieve scale by reducing time spent on non-value-adding activities and...
CMR Surgical, Versius, Microsoft, robotic surgery
By  Tammy Lovell 12:08 pm June 1, 2021
Cambridge-based med tech firm CMR Surgical is collaborating with Microsoft on a proof of concept to store health data. Clinical data from CMR’s surgical robot, Versius, was stored onto a 75x75mm Microsoft Project Silica glass platter. The new archive storage technology from Microsoft can be safely preserved for more than 10,000 years. Data from hundreds of surgical robotic procedures can be...
HIMSS21Europe
By  Tammy Lovell 02:15 am June 1, 2021
As the world struggles to recover from the outfall of COVID-19, the role of digital health has come under the spotlight. Healthcare experts from the UK will be among the European leaders to discuss this new paradigm at the virtual HIMSS21 & Health 2.0 European Health Conference, on 7-9 June 2021. The UK is known for its world-leading expertise in genomics. Prof Sharon Peacock, executive...
Medical devices, European Commission, MDR, Medical Devices Regulation, COCIR
By  Tammy Lovell 11:50 am May 26, 2021
The EU’s new regulation on medical devices finally came into full application today, following a year’s delay due to the COVID-19 pandemic. According to the European Commission, the Medical Devices Regulation (MDR) seeks to ensure a high level of public health and patient safety taking into account scientific progress. The regulation entered into force in May 2017, replacing the Medical Devices...
AI, IBD, drug discovery
By  Tammy Lovell 03:56 am May 19, 2021
Israeli startup CytoReason today announced a partnership with Swiss multinational, Ferring Pharmaceuticals, to establish new treatments for inflammatory bowel disease (IBD).  This is the first collaboration between the two companies, pairing Ferring’s medical expertise with CytoReason’s artificial intelligence (AI) platform to build cell-centred disease models.  CytoReason is developing a...